Vol 54, No 6 (2020)
Invited Editorial
Published online: 2020-12-31

open access

Page views 969
Article views/downloads 596
Get Citation

Connect on Social Media

Connect on Social Media

Unravelling the colourful tapestry of hereditary transthyretin amyloid polyneuropathy in Poland

Elizabeth A. Mauricio1
Pubmed: 33400257
Neurol Neurochir Pol 2020;54(6):486-487.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Plante-Bordeneuve V. Transthyretin familial amyloid polyneuropathy: an update. J Neurol. 2018; 265(4): 976–983.
  2. Schmidt HH, Waddington-Cruz M, Botteman MF, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018; 57(5): 829–837.
  3. Hawkins PN, Ando Y, Dispenzeri A, et al. Evolving landscape in the management of transthyretin amyloidosis. Ann Med. 2015; 47(8): 625–638.
  4. Cortese A, Vegezzi E, Lozza A, et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry. 2017; 88(5): 457–458.
  5. Planté-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology. 2007; 69(7): 693–698.
  6. Adams D, Lozeron P, Lacroix C. Amyloid neuropathies. Curr Opin Neurol. 2012; 25(5): 564–572.
  7. Lipowska M, Drac H, Rowczenio D, et al. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland- genetic and clinical presentations. Neurol Neurochir Pol. ; 2020.
  8. Gawor M, Holcman K, Franaszczyk M, et al. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis. Cardiol J. 2020 [Epub ahead of print].



Neurologia i Neurochirurgia Polska